Fuller & Thaler Asset Management, Inc. Standard Biotools Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$4.63 - $12.15 $1.03 Million - $2.72 Million	-223,511 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$11.49 - $14.17 $14,707 - $18,137	-1,280 Reduced 0.57%	223,511 $2.75 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $31,339 - $53,132	3,700 Added 1.67%	224,791 $2.99 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $28,935 - $35,584	4,030 Added 1.86%	221,091 $1.91 Million
Q1 2018 May 14, 2018	SELL	$5.75 - $7.97 $96,025 - $133,099	-16,700 Reduced 7.14%	217,061 $1.27 Million
Q4 2017 Feb 12, 2018	SELL	$4.46 - $6.45 $318,444 - $460,530	-71,400 Reduced 23.4%	233,761 $1.38 Million
Q3 2017 Nov 08, 2017	BUY	$3.55 - $5.49 $80,585 - $124,623	22,700 Added 8.04%	305,161 $1.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	282,461	282,461 $1.14 Million

143

276M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $122M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.